Clinical trials for non–small cell lung cancer (NSCLC) are increasingly demanding tumor samples or research biopsies, which may bar participation and delay treatment for patients, a new study finds.
The need for...
Clinical trials for non–small cell lung cancer (NSCLC) are increasingly demanding tumor samples or research biopsies, which may bar participation and delay treatment for patients, a new study finds.
The need for...
...